COOPERATION

M€ in open calls for proposals for a total Budget of 32.413 M€.
Grants for collaborative R&D Projects involving more than 2 independent entities established in 2 or more EU Member or Associated States, for the development of innovative products, services or processes.

Need funding for your R&D project?


  GRANTS FOR KNOWLEDGE MANAGEMENT
JTI-IMI-Call7-1 Developing a framework for rapid assessment of vaccionation benefit/risk in Europe CALL CLOSED
Overall Objetives:The long-term vision behind this call is an efficient and sustainable infrastructure for rapid and integrated assessment of post-approval benefit/risk of vaccines under clear governance rules meeting the common interest of all main...
JTI-IMI-Call7-1 Developing a framework for rapid assessment of vaccionation benefit/risk in Europe CALL CLOSED
Overall Objetives:The long-term vision behind this call is an efficient and sustainable infrastructure for rapid and integrated assessment of post-approval benefit/risk of vaccines under clear governance rules meeting the common interest of all main...
JTI-IMI-Call7-1 Conduct of clinical studies suporting the development of Media4893, a monoclonal antibody targetings antibody targeting staphylococcus aureus alpha toxin CALL CLOSED
This topic is part of the topic 1 “Innovative trial design and clinical drug development” of the NewDrugs4BadBugs (ND4BB) Programme which, in turn, is a core element of the “Action plan against the rising threats from Antimicrobial Resistance”...
JTI-IMI-Call7-1 Conduct of clinical studies suporting the development of Media4893, a monoclonal antibody targetings antibody targeting staphylococcus aureus alpha toxin CALL CLOSED
This topic is part of the topic 1 “Innovative trial design and clinical drug development” of the NewDrugs4BadBugs (ND4BB) Programme which, in turn, is a core element of the “Action plan against the rising threats from Antimicrobial Resistance”...
JTI-IMI-Call7-2 Incorporating real-life clinical data into drug development CALL CLOSED
Overall objetives:It is critical to focus the research objectives on disease areas where value is most likely to be delivered to patients and health care systems, in particular in diabetes, cardiovascular diseases, respiratory, oncology, and neurology.-...
JTI-IMI-Call9-1 WEBAE - Leveraging emerging technology for pharmacovigilance CALL CLOSED
Overall objectivesThe primary goal of this partnership is to develop a technical and policy framework for mining publicly available (and licensed) web and social media content outside the control or sponsorship of pharmaceutical and biotechnology...
"New knowledge" is the main product of IMI activities. At the same time existing knowledge is a fundamental requirement in IMI research. Therefore, Knowledge Management has a specific position within IMI.